Prosocial effects of oxytocin in two mouse models of autism spectrum disorders

Neuropharmacology

Volumn 72, Issue , 2013, Pages 187-196

  Teng, Brian L ^a,b   Nonneman, Randal J ^a   Agster, Kara L ^a   Nikolova, Viktoriya D ^a   Davis, Tamara T ^a,b   Riddick, Natallia V ^a   Baker, Lorinda K ^a   Pedersen, Cort A ^a   Jarstfer, Michael B ^a,b   Moy, Sheryl S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina   (United States)

Author keywords

Autism models; Drug discovery; Oxytocin; Repetitive behaviour; Sociability; Stereotypy

Indexed keywords

OXYTOCIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BLOOD BRAIN BARRIER; COMPULSION; CONTROLLED STUDY; DECISION MAKING; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; EXPLORATORY BEHAVIOR; FEMALE; GROOMING; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; SEDATION; SINGLE DRUG DOSE; SOCIAL DISABILITY; STEREOTYPY; TRANQUILIZING ACTIVITY;

EID: 84884826688     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.04.038     Document Type: Article

References (75)

1. Anagnostou, E., Soorya, L., Chaplin, W., Bartz, J., Halpern, D., Wasserman, S., Wang, A.T., Pepa, L., Tanel, N., Kushki, A., 2012. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol. Autism 3, 16.
2. Andari, E., Duhamel, J.R., Zalla, T., Herbrecht, E., Leboyer, M., Sirigu, A., 2010. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc. Natl. Acad. Sci. U. S. A. 107, 4389-4394.
3. Arletti, R., Bertolini, A., 1987. Oxytocin acts as an antidepressant in two animal models of depression. Life Sci. 41, 1725-1730. (Pubitemid 18013802)
4. Armstrong,W.E., Stern, J.E., Teruyama, R., 2002. Plasticity in the electrophysiological properties of oxytocin neurons. Microsc. Res. Tech. 56, 73-80. (Pubitemid 34087757)
5. Bale, T.L., Dorsa, D.M., Johnston, C.A.,1995. Oxytocin receptormRNA expression in the ventromedial hypothalamus during the estrous cycle. J. Neurosci.15, 5058-5064.
6. Bowen, M.T., Carson, D.S., Spiro, A., Arnold, J.C., McGregor, I.S., 2011. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PloS One 6, e27237.
7. Brodkin, E.S., 2007. BALB/c mice: low sociability and other phenotypes that may be relevant to autism. Behav. Brain Res. 176, 53-65. (Pubitemid 44879621)
8. Brodkin, E.S., Hagemann, A., Nemetski, S.M., Silver, L.M., 2004. Social approach e avoidance behavior of inbred mouse strains towards DBA/2 mice. Brain Res. 1002, 151-157. (Pubitemid 38251589)
9. Brussaard, A.B., Kits, K.S., De Vlieger, T.A., 1996. Postsynaptic mechanism of depression of GABAergic synapses by oxytocin in the supraoptic nucleus of immature rat. J. Physiol. 497, 495-507. (Pubitemid 26418114)
10. Busnardo, C., Crestani, C.C., Resstel, L.B.M., Tavares, R.F., Antunes-Rodrigues, J., Corrêa, F.M.A., 2012. Ionotropic glutamate receptors in hypothalamic paraventricular and supraoptic nuclei mediate vasopressin and oxytocin release in unanesthetized rats. Endocrinology 153, 2323-2331.
11. Carrasco, M., Volkmar, F.R., Bloch, M.H., 2012. Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics 129, e1301ee1310.
12. CDC, 2012. Prevalence of autism spectrum disorders e autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR 61, 1-19.
13. Chadman, K.K., 2011. Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol. Biochem. Behav. 97, 586-594.
14. Chini, B., Manning, M., 2007. Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges. Biochem. Soc. Trans. 35, 737-741. (Pubitemid 47310357)
15. Coirini, H., Johnson, A.E., Schumacher, M., McEwen, B.S., 1992. Sex differences in the regulation of oxytocin receptors by ovarian steroids in the ventromedial hypothalamus of the rat. Neuroendocrinology 55, 269-275.
16. Cushing, B.S., Carter, C.S., 2000. Peripheral pulses of oxytocin increase partner preferences in female, but not male, prairie voles. Horm. Behav. 37, 49-56. (Pubitemid 30155450)
17. de Kloet, E.R., Voorhuis, D.A., Boschma, Y., Elands, J., 1986. Estradiol modulates density of putative 'oxytocin receptors' in discrete rat brain regions. Neuroendocrinology 44, 415-421. (Pubitemid 17203952)
18. Eaton, J.L., Roache, L., Nguyen, K.N., Cushing, B.S., Troyer, E., Papademetriou, E., Raghanti, M.A., 2012. Organizational effects of oxytocin on serotonin innervation. Dev. Psychobiol. 54, 92-97.
19. Elsabbagh, M., Divan, G., Koh, Y.J., Kim, Y.S., Kauchali, S., Marcín, C., Montiel-Nava, C., Patel, V., Paula, C.S., Wang, C., 2012. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 5, 160-179.
20. Feifel, D., Macdonald, K., Nguyen, A., Cobb, P.,Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., 2010. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol. Psychiatry 68, 678-680.
21. Fiorino, D.F., Phillips, A.G., 1999. Facilitation of sexual behavior in male rats following d-amphetamine-induced behavioral sensitization. Psychopharmacology 142, 200-208. (Pubitemid 29190856)
22. Gould, G.G., Hensler, J.G., Burke, T.F., Benno, R.H., Onaivi, E.S., Daws, L.C., 2011. Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5- HT2A receptors, and effects of their targeting on BTBR T+ tf/J mouse social behavior. J. Neurochem. 116, 291-303.
23. Grauer, S.M., Pulito, V.L., Navarra, R.L., Kelly, M.P., Kelley, C., Graf, R., Langen, B., Logue, S., Brennan, J., Jiang, L., 2009. Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia. J. Pharmacol. Exp. Ther. 331, 574-590.
24. Guastella, A.J., Einfeld, S.L., Gray, K.M., Rinehart, N.J., Tonge, B.J., Lambert, T.J., Hickie, I.B., 2010. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 67, 692-694.
25. Higashida, H., Yokoyama, S., Huang, J.J., Liu, L., Ma, W.J., Akther, S., Higashida, C., Kikuchi, M., Minabe, Y., Munesue, T., 2012. Social memory, amnesia, and autism: brain oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38. Neurochem. Int. 61, 828-838.
26. Hollander, E., Bartz, J., Chaplin, W., Phillips, A., Sumner, J., Soorya, L., Anagnostou, E., Wasserman, S., 2007. Oxytocin increases retention of social cognition in autism. Biol. Psychiatry 61, 498-503. (Pubitemid 46185336)
27. Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C.M., Aronowitz, B.R., Mosovich, S., 2003. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 28, 193-198.
28. Insel, T.R., 2010. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 65, 768-779.
29. Insel, T.R., Hulihan, T.J., 1995. A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. Behav. Neurosci. 109, 782-789.
30. Israel, J.M., Poulain, D.A., 2000. 17b-Oestradiol modulates in vitro electrical properties and responses to kainate of oxytocin neurones in lactating rats. J. Physiol. 524, 457-470. (Pubitemid 30229511)
31. Jacome, L.F., Burket, J.A., Herndon, A.L., Cannon, W.R., Deutsch, S.I., 2011. D-serine improves dimensions of the sociability deficit of the genetically-inbred Balb/c mouse strain. Brain Res. Bull. 84, 12-16.
32. Johns, J.M., Nelson, C.J., Meter, K.E., Lubin, D.A., Couch, C.D., Ayers, A., Walker, C.H., 1998. Dose-dependent effects of multiple acute cocaine injections on maternal behavior and aggression in Sprague-Dawley rats. Dev. Neurosci. 20, 525-532. (Pubitemid 29000905)
33. Jørgensen, H., Riis, M., Knigge, U., Kjaer, A., Warberg, J., 2003. Serotonin receptors involved in vasopressin and oxytocin secretion. J. Neuroendocrinol.15, 242-249. (Pubitemid 36266891)
34. Kang, Y.S., Park, J.H., 2000. Brain uptake and the analgesic effect of oxytocin e its usefulness as an analgesic agent. Arch. Pharm. Res. 23, 391-395.
35. Kikusui, T., Nakanishi, K., Nakagawa, R., Nagasawa, M., Mogi, K., Okanoya, K., 2011. Cross fostering experiments suggest that mice songs are innate. PloS One 6, e17721.
36. Kim, D.H., Jung, J.S., Song, D.K., Suh, H.W., Huh, S.O., Kim, Y.H., 1998. Intracerebroventricular injection-induced increase in plasma corticosterone levels in the mouse: a stress model. J. Pharmacol. Toxicol. Methods 39, 71-73. (Pubitemid 28351151)
37. Kovács, G.L., Faludi, M., Telegdy, G., 1985. Oxytocin diminishes heroin tolerance in mice. Psychopharmacology 86, 377-379. (Pubitemid 15064970)
38. Labrie, V., Lipina, T., Roder, J.C., 2008. Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology 200, 217-230.
39. Lundeberg, T., Uvnäs-Moberg, K., Ågren, G., Bruzelius, G., 1994. Anti-nociceptive effects of oxytocin in rats and mice. Neurosci. Lett. 170, 153-157. (Pubitemid 24117310)
40. McDougle, C.J., Scahill, L., Aman, M.G., McCracken, J.T., Tierney, E., Davies, M., Arnold, L.E., Posey, D.J., Martin, A., Ghuman, J., 2005. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am. J. Psychiatry 162, 1142-1148. (Pubitemid 40770697)
41. McPheeters, M.L., Warren, Z., Sathe, N., Bruzek, J.L., Krishnaswami, S., Jerome, R.N., Veenstra-Vanderweele, J., 2011. A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127, e1312-e1321.
42. Melis, M.R., Succu, S., Sanna, F., Boi, A., Argiolas, A., 2009. Oxytocin injected into the ventral subiculum or the posteromedial cortical nucleus of the amygdala induces penile erection and increases extracellular dopamine levels in the nucleus accumbens of male rats. Eur. J. Neurosci. 30, 1349-1357.
43. Meyer-Lindenberg, A., Domes, G., Kirsch, P., Heinrichs, M., 2011. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 12, 524-538.
44. Miller, F.D., Ozimek, G., Milner, R.J., Bloom, F.E., 1989. Regulation of neuronal oxytocin mRNA by ovarian steroids in the mature and developing hypothalamus. Proc. Natl. Acad. Sci. U. S. A. 86, 2468-2472. (Pubitemid 19102530)
45. Morin, V., Del Castillo, J.R., Authier, S., Ybarra, N., Otis, C., Gauvin, D., Gutkowska, J., Troncy, E., 2008. Evidence for non-linear pharmacokinetics of oxytocin in anesthetizetized rat. J. Pharm. Pharm. Sci. 11, 12-24.
46. Moy, S.S., Breese, G.R., 2002. Phencyclidine supersensitivity in rats with neonatal dopamine loss. Psychopharmacology 161, 255-262. (Pubitemid 34591663)
47. Moy, S.S., Nadler, J.J., Perez, A., Barbaro, R.P., Johns, J.M., Magnuson, T.R., Piven, J., Crawley, J.N., 2004. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 3, 287-302. (Pubitemid 39277416)
48. Moy, S.S., Nadler, J.J., Young, N.B., Nonneman, R.J., Segall, S.K., Andrade, G.M., Crawley, J.N., Magnuson, T.R., 2008. Social approach and repetitive behavior in eleven inbred mouse strains. Behav. Brain Res. 191, 118-129.
49. Moy, S.S., Nadler, J.J., Young, N.B., Perez, A., Holloway, L.P., Barbaro, R.P., Barbaro, J.R., West, L.M., Threadgill, D.W., Lauder, J.M., 2007. Mouse behavioral tasks relevant to autism: phenotypes of ten inbred strains. Behav. Brain Res. 176, 4-20. (Pubitemid 44879623)
50. Nadler, J.J., Moy, S.S., Dold, G., Trang, D., Simmons, N., Perez, A., Young, N.B., Barbaro, R.P., Piven, J., Magnuson, T.R., 2004. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav. 3, 303-314. (Pubitemid 39277417)
51. Nazeer, A., Ghaziuddin, M., 2012. Autism spectrum disorders: clinical features and diagnosis. Pediatr. Clin. North. Am. 59, 19-25.
52. Ninan, I., 2011. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J. Neurochem. 119, 324-331.
53. Pampillo, M., del Carmen, D.M., Duvilanski, B., Rettori, V., Seilicovich, A., Lasaga, M., 2001. Differential effects of glutamate agonists and D-aspartate on oxytocin release from hypothalamus and posterior pituitary of male rats. Endocrine 15, 309-315. (Pubitemid 33096236)
54. Panksepp, J.B., Jochman, K.A., Kim, J.U., Koy, J.J., Wilson, E.D., Chen, Q., Wilson, C.R., Lahvis, G.P., 2007. Affiliative behavior, ultrasonic communication and social reward are influenced by genetic variation in adolescent mice. PloS One 2, e351.
55. Patisaul, H.B., Scordalakes, E.M., Young, L.J., Rissman, E.F., 2003. Oxytocin, but not oxytocin receptor, is regulated by oestrogen receptor beta in the female mouse hypothalamus. J. Neuroendocrinol. 15, 787-793. (Pubitemid 36880737)
56. Pedersen, C.A., Gibson, C.M., Rau, S.W., Salimi, K., Smedley, K.L., Casey, R.L., Leserman, J., Jarskog, L.F., Penn, D.L., 2011. Intranasal oxytocin reduces psychotic symptoms and improves theory of mind and social perception in schizophrenia. Schizophr. Res. 132, 50-53.
57. Ring, R.H., Malberg, J.E., Potestio, L., Ping, J., Boikess, S., Luo, B., Schechter, L.E., Rizzo, S., Rahman, Z., Rosenzweig-Lipson, S., 2006. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology 185, 218-225. (Pubitemid 43363618)
58. Rosenfeld, A.J., Lieberman, J.A., Jarskog, L.F., 2011. Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia. Schizophr. Bull. 37, 1077-1087.
59. Ryan, B.C., Young, N.B., Crawley, J.N., Bodfish, J.W., Moy, S.S., 2010. Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Behav. Brain Res. 208, 178-188.
60. Sala, M., Braida, D., Lentini, D., Busnelli, M., Bulgheroni, E., Capurro, V., Finardi, A., Donzelli, A., Pattini, L., Rubino, T., 2011. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 69, 875-882.
61. Sankoorikal, G.M.V., Kaercher, K.A., Boon, C.J., Lee, J.K., Brodkin, E.S., 2006. A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains. Biol. Psychiatry 59, 415-423. (Pubitemid 43289220)
62. Saydoff, J.A., Rittenhouse, P.A., van de Kar, L.D., Brownfield, M.S., 1991. Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. J. Pharmacol. Exp. Ther. 257, 95-99.
63. Schorscher-Petcu, A., Sotocinal, S., Ciura, S., Dupré, A., Ritchie, J., Sorge, R.E., Crawley, J.N., Hu, S.B., Nishimori, K., Young, L.J., 2010. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J. Neurosci. 30, 8274-8284.
64. Silverman, J.L., Oliver, C.F., Karras, M.N., Gastrell, P.T., Crawley, J.N., 2013. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology 64, 268-282. http://dx.doi.org/10.1016/j. neuropharm.2012.07.013.
65. Silverman, J.L., Smith, D.G., Rizzo, S.J.S., Karras, M.N., Turner, S.M., Tolu, S.S., Bryce, D.K., Smith, D.L., Fonseca, K., Ring, R.H., Crawley, J.N., 2012b. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci. Transl. Med. 4, 131ra151.
66. Stachnik, J.M., Nunn-Thompson, C., 2007. Use of atypical antipsychotics in the treatment of autistic disorder. Ann. Pharmacother. 41, 626-634. (Pubitemid 46625485)
67. Striepens, N., Kendrick, K.M., Maier, W., Hurlemann, R., 2011. Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Front. Neuroendocrinol. 32, 426-450.
68. Succu, S., Sanna, F., Argiolas, A., Melis, M.R., 2011. Oxytocin injected into the hippocampal ventral subiculum induces penile erection in male rats by increasing glutamatergic neurotransmission in the ventral tegmental area. Neuropharmacology 61, 181-188.
69. Theodosis, D.T., 2002. Oxytocin-secreting neurons: a physiological model of morphological neuronal and glial plasticity in the adult hypothalamus. Front. Neuroendocrinol. 23, 101-135. (Pubitemid 34121909)
70. Theodosis, D.T., Koksma, J.J., Trailin, A., Langle, S.L., Piet, R., Lodder, J.C., Timmerman, J., Mansvelder, H., Poulain, D.A., Oliet, S.H., 2006. Oxytocin and estrogen promote rapid formation of functional GABA synapses in the adult supraoptic nucleus. Mol. Cell. Neurosci. 31, 785-794.
71. Thompson, M.R., Callaghan, P.D., Hunt, G.E., Cornish, J.L., McGregor, I.S., 2007. A role for oxytocin and 5-HT (1A) receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine ("ecstasy"). Neuroscience 146, 509-514. (Pubitemid 46617075)
72. Uvnäs-Moberg, K., Ahlenius, S., Hillegaart, V., Alster, P., 1994. High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol. Biochem. Behav. 49, 101-106.
73. Yamakage, M., Tsujiguchi, N., Chen, X., Kamada, Y., Namiki, A., 2002. Sevoflurane inhibits contraction of uterine smooth muscle from pregnant rats similarly to halothane and isoflurane. Can. J. Anaesth. 49, 62-66. (Pubitemid 34460921)
74. Yamamoto, Y., Cushing, B.S., Kramer, K.M., Epperson, P.D., Hoffman, G.E., Carter, C.S., 2004. Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner. Neuroscience 125, 947-955. (Pubitemid 38553901)
75. Yoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L.J., Onaka, T., Nishimori, K., 2009. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J. Neurosci. 29, 2259-2271. Development